Mutations in RRAS2 are implicated in breast tumorigenesis and metastasis19, while elevated levels of wild-type RRAS2 are found in various cancers, where RRAS2 has been suggested to play a role in immunological development and homeostasis via the PI3K pathway17,20. This evidence concerns the gene PIK3CG and cancer.